Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of the Genetic Determinants of Response to Growth Hormone Treatment in Children With Idiopathic Short Stature

NCT05894876 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT05894876
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05894876 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of the Genetic Determinants of Response to Growth Hormone Treatment in Children With Idiopathic Short Stature
Lead sponsor
Novo Nordisk A/S
Phase
Observational
Overall status
Terminated
Start date
April 29, 2024
Completion date
March 21, 2025
Enrollment
43 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

idiopathic short stature